Henry Nordhoff, who had served as its CEO since 1994, is now non-executive chairman following his re-election to the board at the company’s annual meeting of stockholders last week.
Hank Nordhoff has built a successful and dynamic company in his 15 years at the helm of Gen-Probe, and helped safeguard the health of literally millions of people worldwide through our blood screening and infectious disease testing products, Hull said. I am honored by the opportunity to succeed him, and look forward to his continued guidance as chairman of our board.
Gen-Probe is a developer, manufacturer and marketer of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood.
